AFTATE TRIPLE ANTIBIOTIC- triple antibiotic ointment ointment 
Sabel Med LLC

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Triple Antibiotic Ointment

dosage directions

uses

warnings part 2warnings part 1

keep out of reach

active ingredients

inactive ingredient

purpose

princple display

AFTATE TRIPLE ANTIBIOTIC 
triple antibiotic ointment ointment
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:70356-101
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
POLYMYXIN B SULFATE (UNII: 19371312D4) (POLYMYXIN B - UNII:J2VZ07J96K) POLYMYXIN B5000 [iU]  in 1 g
NEOMYCIN SULFATE (UNII: 057Y626693) (NEOMYCIN - UNII:I16QD7X297) NEOMYCIN3.5 mg  in 1 g
BACITRACIN ZINC (UNII: 89Y4M234ES) (Bacitracin - UNII:58H6RWO52I) Bacitracin400 [iU]  in 1 g
Inactive Ingredients
Ingredient NameStrength
PETROLATUM (UNII: 4T6H12BN9U)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:70356-101-0128 g in 1 TUBE; Type 0: Not a Combination Product05/01/2016
2NDC:70356-101-0514 g in 1 TUBE; Type 0: Not a Combination Product05/01/2016
3NDC:70356-101-339.4 g in 1 TUBE; Type 0: Not a Combination Product05/01/2016
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart333B05/01/2016
Labeler - Sabel Med LLC (091476000)

Revised: 4/2016
Document Id: 2f6e9a84-895d-492d-e054-00144ff8d46c
Set id: 2f6e9a84-895c-492d-e054-00144ff8d46c
Version: 1
Effective Time: 20160401
 
Sabel Med LLC